Axsome Therapeutics, Inc.
AXSM- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001579428
In the last 90 days, Axsome Therapeutics, Inc. insiders filed 0 open-market purchases and 2 sales; 505 institutions reported holding it in 13F filings for Q2 2026, worth $9.34B in total; no superinvestor holds it.
13F holders, Q3 2022
Institutional positions in Axsome Therapeutics, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 188
- +18 vs. Q2 2022
- Shares held
- 25.7M
- +4.10M (+19.0%) vs. Q2 2022
- Total value
- $1.15B
- +$319.5M (+38.7%) vs. Q2 2022
- New holders
- 41
- 69 more added
- Sold out
- 23
- 48 more reduced
4 institutions that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting AXSM on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 505 | $9.34B |
| Q1 2026 | 410 | $6.41B |
| Q4 2025 | 399 | $6.86B |
| Q3 2025 | 355 | $4.51B |
| Q2 2025 | 348 | $3.95B |
| Q1 2025 | 353 | $4.37B |
| Q4 2024 | 292 | $3.15B |
| Q3 2024 | 280 | $3.48B |
| Q2 2024 | 257 | $3.28B |
| Q1 2024 | 259 | $3.09B |
| Q4 2023 | 245 | $3.07B |
| Q3 2023 | 227 | $2.65B |
| Q2 2023 | 231 | $2.61B |
| Q1 2023 | 197 | $1.97B |
| Q4 2022 | 219 | $2.32B |
| Q3 2022 | 188 | $1.15B |
| Q2 2022 | 174 | $826.7M |
| Q1 2022 | 175 | $787.4M |
| Q4 2021 | 167 | $704.2M |
| Q3 2021 | 171 | $627.3M |
| Q2 2021 | 176 | $1.51B |
| Q1 2021 | 184 | $1.31B |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Axsome Therapeutics, Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Quantbot Technologies LP | 0 | $0 | 0.00% | −8,178−100.0% | Sold out |
| Y-Intercept (Hong Kong) Ltd | 0 | $0 | 0.00% | −7,715−100.0% | Sold out |
| Kaizen Financial Strategies | 0 | $0 | 0.00% | −7,500−100.0% | Sold out |
| Spire Wealth Management | 0 | $0 | 0.00% | −7,000−100.0% | Sold out |
| D. E. Shaw & Co., Inc. | 0 | $0 | 0.00% | −6,762−100.0% | Sold out |
| SG3 Management, LLC | 0 | $0 | 0.00% | −4,000−100.0% | Sold out |
| Captrust Financial Advisors | 0 | $0 | 0.00% | −705−100.0% | Sold out |
| Tilia Fiduciary Partners, Inc. | 0 | $0 | 0.00% | −136−100.0% | Sold out |
| Farmers & Merchants Investments Inc | 0 | $0 | 0.00% | −102−100.0% | Sold out |
| Financial Management Professionals, Inc. | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| State of Wyoming | 0 | $0 | 0.00% | −52−100.0% | Sold out |
| Exane Derivatives | – | – | – | – | Not filed |
| Private Capital Group, LLC | – | – | – | – | Not filed |
| Urban Wealth Management, LLC | – | – | – | – | Not filed |
| Cordasco Financial Network | – | – | – | – | Not filed |